41 results
8-K
EX-10.1
KA
Kineta Inc
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
), email, or air courier guaranteeing overnight delivery, to the other party at the following address.
SMARTLABS
LICENSEE
40 Guest Street
Boston, MA … or Licensee’s Occupants into the air, surface water, sewers, soil or groundwater of any Hazardous Material (defined below) whether within or outside the Licensed
S-4
EX-10.18
KA
Kineta Inc
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
but not limited to any discharge by Licensee or Licensee’s Occupants into the air, surface water, sewers, soil or groundwater of any Hazardous Material
425
EX-10.1
KA
Kineta Inc
15 Dec 20
Business combination disclosure
7:32am
of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law
8-K
EX-10.1
5k4 thm7i0bj
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
8-K
EX-1.1
14qwgut73wk
24 Oct 18
Entry into a Material Definitive Agreement
4:28pm
8-K
EX-1.1
8s3nsaxn
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
co6alud5oa7zfbz8 ob
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
8-K
EX-10.1
bzmqko3ky6pnrt1kk
5 Oct 23
Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K/A
EX-99.1
cxorcksmqu ih0aqui1
3 Feb 21
Other Events
4:59pm
10-K
75ijfrhpqi49kcvp
30 Mar 16
Annual report
12:00am
8-K
EX-99.5
ii7 mjdblx2k7w
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-2.2
rm5xhiezjuiq c3o
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm